112 results
DEFA14A
LRMR
Larimar Therapeutics Inc
19 Aug 20
Additional proxy soliciting materials
6:13am
Materials
Soliciting Material under Rule 14a-12
Larimar Therapeutics, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing … with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which
DEFA14A
LRMR
Larimar Therapeutics Inc
18 May 20
Additional proxy soliciting materials
9:55pm
Materials
Soliciting Material Pursuant to§240.14a-12
ZAFGEN, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy … with preliminary materials.
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
8-K
LRMR
Larimar Therapeutics Inc
9 Mar 20
Entry into a Material Definitive Agreement
12:00am
and Exchange Commission (“SEC”) a preliminary proxy statement and other relevant materials in connection with the proposed transactions … in respect of the proposed merger involving Zafgen and Chondrial. In connection with the proposed merger, Zafgen intends to file relevant materials
DEFA14A
LRMR
Larimar Therapeutics Inc
9 Mar 20
Additional proxy soliciting materials
12:00am
and Exchange Commission (“SEC”) a preliminary proxy statement and other relevant materials in connection with the proposed transactions … in respect of the proposed merger involving Zafgen and Chondrial. In connection with the proposed merger, Zafgen intends to file relevant materials
DEFA14A
eizdka fvbyedm532n
18 Dec 19
Additional proxy soliciting materials
8:11am
DEFA14A
h0rcuisr quy76g
5 Feb 20
Additional proxy soliciting materials
4:31pm
S-1
EX-10.6
vtj6 4v7y
18 Apr 14
IPO registration
12:00am
8-K
EX-99.3
9my5w50ier ms9m2u
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
DEFA14A
EX-99.3
k4r7is52he
18 Dec 19
Additional proxy soliciting materials
8:11am
8-K
EX-99.1
s6gu g0e1lzq27kyr0jo
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
8-K
EX-99.1
e9jcx
5 Feb 20
Regulation FD Disclosure
4:30pm
DEFA14A
EX-99.1
lboeand 10
18 Dec 19
Additional proxy soliciting materials
8:11am
8-K
2gm9c3s 4q
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
DEFA14A
EX-99.2
usxh2fq2 kyw9gfix08
18 Dec 19
Additional proxy soliciting materials
8:11am
8-K
EX-99.2
393xvwl32j801uv9mp9
18 Dec 19
Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement
8:13am
DEFA14A
EX-99.1
u4f41hyokrl2
13 Jan 20
Additional proxy soliciting materials
7:15am
8-K
EX-99.1
odwfmo8
5 Mar 20
Zafgen Reports Fourth Quarter and Full Year 2019 Financial Results
4:16pm